1834 Investment Advisors’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
– Sell
-78
Closed -$7K – 509
2021
Q2
$7K Buy
+78
New +$6.95K ﹤0.01% 446
2019
Q3
– Sell
-17
Closed -$2K – 484
2019
Q2
$2K Sell
17
-2
-11% -$169 ﹤0.01% 418
2019
Q1
$2K Hold
19
– – ﹤0.01% 393
2018
Q4
$1K Hold
19
– – ﹤0.01% 395
2018
Q3
$1K Hold
19
– – ﹤0.01% 392
2018
Q2
$1K Hold
19
– – ﹤0.01% 410
2018
Q1
$1K Hold
19
– – ﹤0.01% 437
2017
Q4
$1K Buy
+19
New +$1.43K ﹤0.01% 448
2015
Q3
– Sell
-3,139
Closed -$277K – 200
2015
Q2
$277K Sell
3,139
-468
-13% -$42.9K 0.08% 136
2015
Q1
$319K Buy
3,607
+87
+2% +$7.72K 0.09% 133
2014
Q4
$292K Sell
3,520
-2,477
-41% -$205K 0.08% 134
2014
Q3
$506K Sell
5,997
-1,167
-16% -$94.4K 0.14% 106
2014
Q2
$581K Sell
7,164
-909
-11% -$71.5K 0.16% 107
2014
Q1
$615K Sell
8,073
-1,836
-19% -$134K 0.18% 93
2013
Q4
$714K Sell
9,909
-224
-2% -$15.6K 0.21% 95
2013
Q3
$697K Sell
10,133
-1,483
-13% -$98.1K 0.23% 86
2013
Q2
$736K Buy
+11,616
New +$756K 0.25% 84

Other funds holding NVS

1834 Investment Advisors's NVS Position: Q3 2021 in Review

1834 Investment Advisors sold out of Novartis (NVS) in Q3 2021, closing a stake of 78 shares — an estimated $7K sold.

1834 Investment Advisors first reported a position in NVS in Q2 2013 and held it in 17 quarters. The position peaked at $736K in Q2 2013. 1,081 funds tracked by Wall St. Rank hold NVS as of Q3 2021.

  • 1834 Investment Advisors reported no remaining Novartis position as of Q3 2021 after selling out during the quarter.
  • 1834 Investment Advisors sold 78 Novartis shares in Q3 2021, an estimated $7K.
  • 1834 Investment Advisors first reported a position in Novartis in Q2 2013 and held it in 17 quarters.
  • 1834 Investment Advisors's Novartis position peaked at $736K in Q2 2013.
  • 1,081 funds tracked by Wall St. Rank held Novartis as of Q3 2021.

Based on 1834 Investment Advisors's 13F filing for Q3 2021, filed 15 Nov 2021.